Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency

Brain Research

Volumn 1552, Issue , 2014, Pages 34-40

  Fan, X T ^a,b   Zhao, F ^b,c   Ai, Y ^b   Andersen, A ^b   Hardy, P ^b   Ling, F ^a   Gerhardt, G A ^b   Zhang, Z ^b   Quintero, J E ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cortical; Glutamate; Microelectrode array; MPTP; Parkinson's

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLUTAMIC ACID;

AMPEROMETRY; ANIMAL EXPERIMENT; ARTICLE; BIOSENSOR; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; FEMALE; MICROELECTRODE; MOTOR CORTEX; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PRIMATE; PRIMATE MODEL; PRIORITY JOURNAL; RHESUS MONKEY; SUBSTANTIA NIGRA;

ANIMALIA; MACACA MULATTA; PRIMATES;

CORTICAL; GLUTAMATE; MICROELECTRODE ARRAY; MPTP; PARKINSON'S;

ANIMALS; BIOSENSING TECHNIQUES; CELL COUNT; DOPAMINE; DOPAMINERGIC NEURONS; ELECTRODES, IMPLANTED; FEMALE; GLUTAMIC ACID; MACACA MULATTA; MICROELECTRODES; MOTOR CORTEX; NERVE TISSUE PROTEINS; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84896719949     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.12.035     Document Type: Article

References (40)

1. G.E. Alexander, M.D. Crutcher, and M.R. DeLong Basal ganglia- thalamocortical circuits: parallel substrates for motor, oculomotor, " prefrontal" and " limbic" functions Prog. Brain Res. 85 1990 119 146
2. L. Bai, P.R. Hof, D.G. Standaert, Y.D. Xing, S.E. Nelson, A.B. Young, and K.R. Magnusson Changes in the expression of the NR2B subunit during aging in macaque monkeys Neurobiol. Aging 25 2004 201 208
3. N.S. Bamford, S. Robinson, R.D. Palmiter, J.A. Joyce, C. Moore, and C.K. Meshul Dopamine modulates release from corticostriatal terminals J. Neurosci. 24 2004 9541 9552
4. B.L. Bloodgood, and B.L. Sabatini Regulation of synaptic signalling by postsynaptic, non-glutamate receptor ion channels J. Physiol. 586 2008 1475 1480
5. J.J. Burmeister, and G.A. Gerhardt Self referencing ceramic based multisite microelectrodes for the detection and elimination of interferences from the measurement of l-glutamate and other analytes Anal. Chem. 73 2001 1037 1042
6. B.K. Day, F. Pomerleau, J.J. Burmeister, P. Huettl, and G.A. Gerhardt Microelectrode array studies of basal and potassium-evoked release of l-glutamate in the anesthetized rat brain J. Neurochem. 96 2006 1626 1635
7. F. Ding, L. Luan, Y. Ai, A. Walton, G.A. Gerhardt, D.M. Gash, R. Grondin, and Z. Zhang Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys Exp. Neurol. 212 2008 431 439
8. N.W. Duncan, B. Enzi, C. Wiebking, and G. Northoff Involvement of glutamate in rest-stimulus interaction between perigenual and supragenual anterior cingulated cortex: a combined fMRI-MRS study Hum Brain Mapp. 32 12 2011 2172 2182
9. A. Galvan, and T. Wichmann Pathophysiology of parkinsonism Clin. Neurophysiol. 119 2008 1459 1474
10. D.M. Gash, Z. Zhang, W.A. Cass, A. Ovadia, L. Simmerman, D. Martin, D. Russell, F. Collins, B.J. Hoffer, and G.A. Gerhardt Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys J. Comp. Neurol. 363 1995 345 358
11. D.M. Gash, Z. Zhang, A. Ovadia, W.A. Cass, A. Yi, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B.J. Hoffer, and G.A. Gerhardt Functional recovery in parkinsonian monkeys treated with GDNF Nature 380 1996 252 255
12. P. Gaspar, C. Duyckaerts, C. Alvarez, F. Javoy-Agid, and B. Berger Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease Ann. Neurol. 30 1991 365 374
13. H.R. Griffith, O.C. Okonkwo, T. O'Brien, and J.A. Hollander Reduced brain glutamate in patients with Parkinson's disease NMR Biomed. 21 2008 381 387
14. R. Grondin, Z. Zhang, A. Yi, W.A. Cass, N. Maswood, A.H. Andersen, D.D. Elsberry, M.C. Klein, G.A. Gerhardt, and D.M. Gash Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys Brain 125 2002 2191 2201
15. P.R. Hof, H. Duan, T.L. Page, M. Einstein, B. Wicinski, Y. He, J.M. Erwin, and J.H. Morrison Age-related changes in GluR2 and NMDAR1 glutamate receptor subunit protein immunoreactivity in corticocortically projecting neurons in macaque and patas monkeys Brain Res. 928 2002 175 186
16. C. Jan, M. Pessiglione, L. Tremblay, D. Tandé, E.C. Hirsch, and C. François Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys Eur. J. Neurosci. 18 2003 2082 2086
17. E. Korkotian, and M. Segal Spike-associated fast contraction of dendritic spines in cultured hippocampal neurons Neuron 30 2001 751 758
18. N. Kuninobu, C.M. Ann, and W.K. Neil Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients Acta Neuropathol. 86 1993 55 64
19. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
20. J.P. Lefaucheur Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation Clin. Neurophysiol. 116 2005 244 253
21. J. Lippman, and A. Dunaevsky Dendritic spine morphogenesis and plasticity J. Neurobiol. 64 2005 47 57
22. L. Luan, F. Ding, Y. Ai, A. Andersen, P. Hardy, E. Forman, G.A. Gerhardt, D.M. Gash, R. Grondin, and Z. Zhang Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys Cell Transplant. 17 2008 417 425
23. R.A. McKinney Physiological roles of spine motility: development, plasticity and disorders Biochem. Soc. Trans. 33 2005 1299 1302
24. J. Nickell, M.F. Salvatore, F. Pomerleau, S. Apparsundaram, and G.A. Gerhardt Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum Neurobiol Aging 28 11 2007 1737 1748
25. A. Ovadia, Z. Zhang, and D.M. Gash Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys Neurobiol. Aging 16 1995 931 937
26. A. Parent, and L.N. Hazrati Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop Brain Res. Brain Res. Rev. 20 1995 91 127
27. M. Passafaro, T. Nakagawa, C. Sala, and M. Sheng Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2 Nature 424 2003 677 681
28. G.M. Petzinger, D.M. Togasaki, G. Akopian, J.P. Walsh, and M.W. Jakowec Non-human primate models of Parkinson's disease and experimental therapeutics N. Richard, P. Serge, Parkinson's Disease 2008 Academic Press San Diego 105 132
29. C. Pifl, G. Schingnitz, and O. Hornykiewicz Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey Neuroscience 44 1991 591 605
30. J.E. Quintero, B.K. Day, Z. Zhang, R. Grondin, M.L. Stephens, P. Huettl, F. Pomerleau, D.M. Gash, and G.A. Gerhardt Amperometric measures of age-related changes in glutamate regulation in the cortex of rhesus monkeys Exp. Neurol. 208 2007 238 246
31. M.C. Ridding, R. Inzelberg, and J.C. Rothwell Changes in excitability of motor cortical circuitry in patients with Parkinson's disease Ann. Neurol. 37 1995 181 188
32. U. Sabatini, K. Boulanouar, N. Fabre, F. Martin, C. Carel, C. Colonnese, L. Bozzao, I. Berry, J.L. Montastruc, F. Chollet, and O. Rascol Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study Brain 123 2000 394 403
33. J.S. Schneider, D.W. Anderson, and E. Decamp 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced mammalian models of Parkinson's disease: potential uses and misuses of acute, sub-acute, and chronic models N. Richard, P. Serge, Parkinson's Disease 2008 Academic Press San Diego 87 103
34. R.J. Schwartzman, and G.M. Alexander Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease Brain Res. 358 1985 137 143
35. R.L. Watts, and A.S. Mandir The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism Neurol. Clin. 10 1992 451 469
36. T. Wichmann, and M.R. DeLong Pathophysiology of parkinsonian motor abnormalities Adv. Neurol. 60 1993 53 61
37. T. Wichmann, and M.R. DeLong Functional and pathophysiological models of the basal ganglia Curr. Opin. Neurobiol. 6 1996 751 758
38. T. Wichmann, and M.R. DeLong Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder Ann. N. Y. Acad. Sci. 991 2003 199 213
39. T. Wichmann, and M.R. DeLong Systems level physiology of the basal ganglia, and pathophysiology of Parkinson's disease R. Nass, S. Przedborski, Parkinson's Disease: Molecular and Therapeutic Insights from Model Systems 2008 Academic Press Amesterdam 55 63
40. Z. Zhang, and D.M. Gash Introduction to: neurotoxin-based nonhuman primate models of Parkinson's disease R. Nass, S. Przedborski, Parkinson's Disease: Molecular and Therapeutic Insights from Model Systems 2008 Academic Press Amsterdam 51 54